Alfa Laval and Millipore Sign Joint Marketing Agreement To Integrate Centrifugation with Depth Filtration.To download high-resolution, print-ready JPEG JPEG in full Joint Photographic Experts Group Standard computer file format for storing graphic images in a compressed form for general use. JPEG images are compressed using a mathematical algorithm. images, click on the thumbnail image above. WARNING: these images are very large (800K+) Click here for caption Business Editors/Health/Medical Writers BIOWIRE2K NOTE TO MEDIA: Multimedia assets available A photo is available at URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. : http://www.businesswire.com/cgi-bin/photo.cgi?pw.072803/bb4 BILLERICA, Mass. and RICHMOND, Va.--(BUSINESS WIRE)--July 28, 2003 Alfa Laval Alfa Laval AB is a Swedish company, founded in 1883 by Gustaf de Laval and Oscar Lamm. The company is a leading producer of specialized products and solutions used to heat, cool, separate and transport products such as oil, water, chemicals, beverages, foodstuffs, starch and Inc., a global leader in high-speed separators, and Millipore Corporation For other uses, see Millipore. Millipore Corporation (NYSE: MIL) founded in 1954, listed among the S&P 500 since the early 1990s, is an international biosciences company, known widely for its micrometer pore-size filters and tests. (NYSE NYSE See: New York Stock Exchange : MIL), a multinational bioscience company, today announced a USA joint marketing agreement for Millipore's multi-layer Millistak+(R) HC depth filters and Alfa Laval's high-speed biotechnology centrifuges. This integration of equipment will allow the efficient recovery of biopharmaceutical proteins generated by cell culture and fermentation. "The first steps in drug recovery after a bioreactor bioreactor a container in which living organisms carry out a biological reaction. are often the most challenging and require a series of separation and filtration steps. In working with a leader like Millipore, we are able to provide our customers with an optimal solution for primary recovery," said Kirk Spitzer, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. at Alfa Laval Inc. Under the terms of the agreement, each company will exclusively promote the other company's products to customers requiring centrifugation Centrifugation A mechanical method of separating immiscible liquids or solids from liquids by the application of centrifugal force. This force can be very great, and separations which proceed slowly by gravity can be speeded up enormously in centrifugal and depth filtration. Furthermore, this partnership encompasses assistance with sales activities, preparation and publication of technical articles, joint field testing and customer demonstrations of this centrifugation and depth filtration combination. "The expertise from both companies will speed the drug development process and enhance customer process economics. Integrating and optimizing the key technologies of centrifugal centrifugal /cen·trif·u·gal/ (sen-trif´ah-gal) efferent (1). cen·trif·u·gal adj. 1. Moving or directed away from a center or axis. 2. separation and depth filtration will improve customers' process efficiency, lower capital costs and reduce operating costs operating costs npl → gastos mpl operacionales ," said Susan Vogt, president of Millipore's BioPharmaceutical division. Millipore's Millistak+ HC depth filters combine two distinct separation technologies-charged depth media and membrane-to enhance filter capacity and retention. Designed for removing whole cells or colloidal colloidal of the nature of a colloid. colloidal bath a bath containing gelatin, bran, starch or similar substances, to relieve skin irritation and pruritus. particulates in mammalian cell culture applications, Millistak+ HC filters compress multiple stages of downstream bioreactor processes into one efficient step. Available in multiple formats and sizes, they are ideal for small batch processing (1) Performing a particular operation automatically on a group of files all at once rather than manually opening, editing and saving one file at a time. For example, graphics software that converts a selection of images from one format to another would be a batch processing utility. and direct scale-up to large volume commercial production. About Millipore Millipore is a multinational, bioscience company that provides technologies, tools and services for the discovery, development and production of new therapeutic drugs. It serves the life science research, biotechnology and pharmaceutical industries. For more information about Millipore visit www.millipore.com. About Alfa Laval Inc. Alfa Laval, with global headquarters in Lund, Sweden, is a leading global provider of specialized products and engineering solutions. The equipment, systems and service are dedicated to assisting customers in optimizing the performance of their processes. The company helps their customers to heat, cool, separate and transport products such as oil, water, chemicals, beverages, foodstuff, starch and pharmaceuticals. Alfa Laval is a global market leader with its three key technologies - Centrifugal Separation, Heat Transfer and Fluid Handling. For more information, visit www.alfalaval.us. Millipore Forward Looking Statement Disclaimer The matters discussed herein, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. , are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Potential risks and uncertainties that could affect Millipore's future operating results include, without limitation, foreign exchange rates; regulatory delay in the approval of new therapeutics; further consolidation of drug manufacturers; competitive factors such as new membrane technology; lack of availability of raw materials or component products on a timely basis; inventory risks due to shifts in market demand; change in product mix; conditions in the economy in general and in the bioscience markets in particular; potential environmental liabilities; the inability to utilize technology in current or planned products due to overriding rights by third parties; difficulties inherent in research and development activities; and the risk factors listed from time to time in Millipore's filings with the SEC. Millistak+ and Millipore are registered trademarks of Millipore Corporation. Note: A photo is available at URL: http://www.businesswire.com/cgi-bin/photo.cgi?pw.072803/bb4 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion